Tom Dunlap Board of Directors Press Release

Search for...

Recent Posts

That’s some nerve! Ocular drug delivery and dry eye
Report From ESCRS Barcelona: Discover the Eye Lipid Mobilizer (ELM)
Senior Ophthalmology Executive Thomas A. (Tom) Dunlap joins Eyedetec Medical, Inc. as an independent member of the Board of Directors to support the company’s business development and commercialization initiatives within the Optometric and Ophthalmic markets.
Eye News Media
Invest in Eyedetec: Changing the Future of Dry Eye Therapy